Click to enlarge
US/Silver Spring: GSK Consumer Healthcare, a Warren, New Jersey establishment, recalls two batch/lots of Children’s Robitussin Honey Cough and Chest Congestion DM and one lot of Children’s Dimetapp Cold and Cough from the American marketplace due to suspected inclusion of incorrect dosing cups and consequential risks of medication overdose and/or medication under-dosage, all serious health hazards.
FDA: http://ht.ly/bC3e30qRUAQ
Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gsk-consumer-healthcare-issues-voluntary-nationwide-recall-childrens-robitussinr-honey-cough-and
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Children’s medications are subject to this recall:
Continue reading →
Filed under: Chemical contamination hazard, Drugs, Labeling or regulatory issues, Medical / Veterinary, US FDA | Tagged: Children's Dimetapp Cold and Cough, Children's Robitussin Honey Cough and Chest Congestion DM, Dimetapp, drug, FDA, GSK Consumer Healthcare, Recalls Direct RIN: 13161-2020, Robitussin, US Food and Drug Administration | Leave a comment »